Adenoid Cystic Carcinoma

Citius Oncology Reports Promising LYMPHIR Cancer Data

CRANFORD, N.J., June 1, 2026 Citius Oncology has announced encouraging Phase 1 clinical findings evaluating LYMPHIR® (denileukin diftitox-cxdl) in...

By cGxPwire Editor
June 2, 2026

Pharma

Servier’s Emi-Le Shows Promise in Rare ACC Cancer Trial

BOSTON, June 1, 2026 Servier has announced encouraging new clinical findings for Emiltatug Ledadotin (Emi-Le), an investigational B7-H4-targeted antibody-drug...

By cGxPwire Editor
June 2, 2026

.Clinical

Rgenta Shows Early ACC Response Data for RGT-61159

WOBURN, Massachusetts, May 21, 2026 Rgenta Therapeutics announced positive preliminary results from its ongoing Phase 1a/b clinical trial evaluating...